https://seekingalpha.com/article/4752978-atai-life-sciences-positive-bpl-003-data-in-aud-leads-to-another-catalyst [Seeking Alpha]
ATAI Life Sciences N.V. - Common Shares (ATAI)
US:NASDAQ Investor Relations:
ir.atai.net.cn
Company Research
Source: Seeking Alpha
Release of results from the phase 2b study using BPL-003 for treatment-resistant depression expected in mid-2025. The global treatment-resistant depression treatment market is projected to reach $4.06 billion by 2030. Atai's diversified pipeline includes RL-007 for cognitive impairment associated with schizophrenia, VLS-01 for TRD, and EMP-01 for social anxiety disorder, with key data readouts in 2025. Looking for a portfolio of ideas like this one? Members of Biotech Analysis Central get exclusive access to our subscriber-only portfolios. Learn More » shulz Atai Life Sciences N.V. NASDAQ: ATAI ) recently reported positive topline results from Beckley Psytech's phase 2a open-label study of BPL-003 for the treatment of 12 patients with moderate-to-s
Read more
Impact Snapshot
Event Time:
ATAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATAI alerts
High impacting ATAI Life Sciences N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
ATAI
News
- atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care ConferenceGlobeNewswire
- Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio [Yahoo! Finance]Yahoo! Finance
- atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common SharesGlobeNewswire
- atai Life Sciences Announces Pricing of Public Offering of Common SharesGlobeNewswire
- atai Life Sciences Announces Proposed Public Offering of Common Shares [Yahoo! Finance]Yahoo! Finance
ATAI
Earnings
- 11/13/24 - Miss
ATAI
Sec Filings
- 2/24/25 - Form SCHEDULE
- 2/19/25 - Form 4
- 2/13/25 - Form 8-K
- ATAI's page on the SEC website